Purchases and Sales Made in Q2 2024 in Biomarin Pharmaceutical Inc (BMRN)
This table provides information about the institutional ownership of Biomarin Pharmaceutical Inc (BMRN) during Q2 2024. The information is specifically focused on institutions that hold shares of BIOMARIN PHARMACEUTICAL INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 13, 2024
Q2 2024
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-242K- 12.72% |
$18M - $22.4M
|
1.66M
$112M
|
|
Jul 29, 2024
Q2 2024
|
Bnp Paribas Asset Management Holding S.A.
|
SELL
|
- |
-253K- 31.67% |
$18.8M - $23.3M
|
545K
$36.7M
|
|
Aug 14, 2024
Q2 2024
|
Bellevue Group Ag
Kuesnacht, V8 |
SELL
|
- |
-270K- 83.77% |
$20.1M - $24.9M
|
52.2K
$3.52M
|
|
Aug 13, 2024
Q2 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-270K- 66.84% |
$20.1M - $24.9M
|
134K
$9.04M
|
|
Aug 12, 2024
Q2 2024
|
Scout Investments, Inc.
|
SELL
|
- |
-288K- 42.56% |
$21.4M - $26.5M
|
388K
$26.2M
|
|
Aug 14, 2024
Q2 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-313K- 57.45% |
$23.3M - $28.9M
|
232K
$15.6M
|
|
Aug 14, 2024
Q2 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-360K- 51.4% |
$26.8M - $33.2M
|
340K
$22.9M
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-426K- 78.56% |
$31.7M - $39.3M
|
116K
$7.83M
|
|
Aug 14, 2024
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-532K- 22.75% |
$39.6M - $49.1M
|
1.81M
$122M
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-640K- 94.52% |
$47.6M - $59M
|
37.1K
$2.5M
|
|
Aug 14, 2024
Q2 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-682K- 97.98% |
$50.8M - $62.9M
|
14.1K
$947K
|
|
Aug 14, 2024
Q2 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-702K- 13.0% |
$52.3M - $64.8M
|
4.7M
$317M
|
|
Aug 14, 2024
Q2 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-758K- 87.96% |
$56.4M - $69.9M
|
104K
$6.99M
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.16M- 50.87% |
$86.2M - $107M
|
1.12M
$75.4M
|
|
Aug 14, 2024
Q2 2024
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-1.25M- 97.96% |
$93.2M - $115M
|
26.1K
$1.76M
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.42M- 71.76% |
$106M - $131M
|
558K
$37.6M
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-1.77M- 63.31% |
$131M - $163M
|
1.02M
$69M
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-4.14M- 78.72% |
$308M - $381M
|
1.12M
$75.4M
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-4.67M- 92.38% |
$348M - $431M
|
386K
$26M
|